Publicacions en col·laboració amb investigadors/es de Hospital Universitario de Cruces (39)

2025

  1. Lipid imaging mass spectrometry: Towards a new molecular histology

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1870, Núm. 1

2024

  1. Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 13

  2. Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy

    Cancers, Vol. 16, Núm. 16

  3. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Author Correction: The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma (Scientific Reports, (2023), 13, 1, (7339), 10.1038/s41598-023-34087-x)

    Scientific Reports

  2. The expression pattern of pyruvate dehydrogenase kinases predicts prognosis and correlates with immune exhaustion in clear cell renal cell carcinoma

    Scientific Reports, Vol. 13, Núm. 1

  3. Using the Synergy between HPLC-MS and MALDI-MS Imaging to Explore the Lipidomics of Clear Cell Renal Cell Carcinoma

    Analytical Chemistry, Vol. 95, Núm. 4, pp. 2285-2293

2021

  1. (Pro)renin receptor is a novel independent prognostic marker in invasive urothelial carcinoma of the bladder

    Cancers, Vol. 13, Núm. 22

  2. Clinical implications of (Pro)renin receptor (prr) expression in renal tumours

    Diagnostics, Vol. 11, Núm. 2

  3. High-Resolution Human Kidney Molecular Histology by Imaging Mass Spectrometry of Lipids

    Analytical Chemistry, Vol. 93, Núm. 27, pp. 9364-9372

  4. Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma

    Cancers, Vol. 13, Núm. 4, pp. 1-17

2020

  1. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases

    Aging, Vol. 12, Núm. 11, pp. 10337-10358

  2. Altered tissue and plasma levels of fibroblast activation protein-α (FAP) in renal tumours

    Cancers, Vol. 12, Núm. 11, pp. 1-16

  3. An integrative omics approach reveals involvement of BRCA1 in hepatic metastatic progression of colorectal cancer

    Cancers, Vol. 12, Núm. 9, pp. 1-24

  4. The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions

    Journal of Advanced Research, Vol. 21, pp. 103-108

2019

  1. (Pro)renin receptor expression increases throughout the colorectal adenoma—Adenocarcinoma sequence and it is associated with worse colorectal cancer prognosis

    Cancers, Vol. 11, Núm. 6

  2. Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence

    International Journal of Medical Sciences, Vol. 16, Núm. 6, pp. 813-821

  3. The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder

    Human Pathology, Vol. 91, pp. 61-68

2018

  1. High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma

    Annals of Diagnostic Pathology, Vol. 34, pp. 27-30

2017

  1. Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients

    PLoS ONE, Vol. 12, Núm. 8